Latest News & Features
Biotechnology
A CRISPR patent filed by scientist Emmanuelle Charpentier alongside the Regents of the University of California and the University of Vienna has been upheld by the Japan Patent Office. 1 June 2021
Americas
A non-fungible token for a Nobel Prize-winning cancer immunotherapy invention has been minted ahead of an auction tomorrow arranged by the University of California, Berkeley. 1 June 2021
Big Pharma
President Xi Jingping has announced his support for waiving IP rights for COVID-19 vaccines. 1 June 2021
Americas
Philips has settled trade secrets and copyright claims against a medical imaging company, having already survived accusations of breaching antitrust law. 27 May 2021
Americas
AbbVie and its exclusive licensee have settled a patent lawsuit against Taro Pharmaceutical over a generic rosacea drug. 27 May 2021
article
Skinny labelling has long allowed generic drugs to be approved for non-patented indications, allowing them to enter the market before the brand-name drug’s patent for other indications expires. In the recent GSK v Teva lawsuits, skinny labelling did not protect Teva from patent infringement and $235 million in damages. 27 May 2021
Big Pharma
Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents. 27 May 2021
Big Pharma
Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights. 25 May 2021
Europe
The University of California Berkeley has lost a CRISPR patent in Europe in the latest twist in the long-running IP saga over the gene-editing technology. 25 May 2021
Big Pharma
The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list. 23 May 2021